Skip to main content
. 2013 Dec 16;8(12):e82195. doi: 10.1371/journal.pone.0082195

Table 2. Products in clinical development at the end of the study.

Phase 1 Phase 2 Phase 3 NDA PPA Approved
ETC 16 18 9 0 24 14
GTC 24 25 10 1 11 3
NTC 7 11 5 0 7 0